Karrie Wong

Company: KSQ Therapeautics

Job title: Senior Director & Head of Cell Therapy

Seminars:

eTIL: Enhancing Anti-Tumor Function through CRISPR/Cas9 Gene Editing 11:30 am

Immune CRISPRomics Platform discovered SOCS1 and Regnase-1 as top gene targets enhancing T-cell anti-tumor function KSQ-001EX and KSQ-004EX are single and dual-edited engineered TIL (eTIL) products with inactivation of SOCS1 and Regnase-1Read more

day: Conference Day One - Track A - AM